Adil Javed to Prospective Studies
This is a "connection" page, showing publications Adil Javed has written about Prospective Studies.
Connection Strength
0.041
-
COVID-19 in multiple sclerosis patients and risk factors for severe infection. J Neurol Sci. 2020 Nov 15; 418:117147.
Score: 0.023
-
Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study. PLoS One. 2017; 12(4):e0173299.
Score: 0.018